Joby Clears Another Regulatory Hurdle, But Certification Progress Remains Modest

What happened

Joby Aviation's latest regulatory milestone reinforces the narrative of advancing toward commercial eVTOL service, but the substance of certification progress remains modest—Stage 4 testing completion was still only 12% (Joby) and 4% (FAA) as of February. The stock's ~$9.6 price reflects a balanced risk/reward, with $2.47B liquidity providing runway but a Q1'26 operating cash burn of $144M keeping dilution sensitivity high. The real signal to watch is disclosed entry into FAA-piloted "for-credit" flight testing, which would validate the Stage 5 narrative that management is promoting. Meanwhile, the ongoing Archer ITC complaint poses an asymmetric downside risk that could delay the program, and manufacturing credibility hinges on Dayton facility operations starting in 2026. Until quarterly filings show accelerating certification throughput alongside stable or improving cash use, the WAIT rating remains appropriate.

Implication

Investors should await the next 10-Q for evidence that Stage 4 completion rates are accelerating and that FAA-piloted credit testing is scheduled. Until then, the risk of dilution and potential ITC disruption outweighs upside. An attractive entry near $8.50 offers a margin of safety if those catalysts materialize, but conviction remains moderate at 3.5/5.

Thesis delta

The news does not materially alter the base case; Stage 4 progress remains low and the ITC litigation unresolved. The thesis continues to hinge on near-term FAA testing cadence, not just headline regulatory clearances.